(Q43791088)

26 November 2017

title

Do CYP3A and ABCB1 genotypes influence the plasma concentration and clinical outcome of donepezil treatment? (English)

1 reference

26 November 2017

Laura Magliulo

1

1 reference

26 November 2017

Marja-Liisa Dahl

2

1 reference

26 November 2017

Grazia Lombardi

3

1 reference

26 November 2017

Silvia Fallarini

4

1 reference

26 November 2017

Laura Maria Villa

5

1 reference

26 November 2017

Aldo Biolcati

6

1 reference

26 November 2017

Maria Gabriella Scordo

7

1 reference

26 November 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20931330

29 July 2024

publication date

8 October 2010

1 reference

full work available at URL

26 November 2017

https://hal.archives-ouvertes.fr/hal-00630268/file/PEER_stage2_10.1007%252Fs00228-010-0883-5.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20931330

http://link.springer.com/content/pdf/10.1007/s00228-010-0883-5.pdf

29 July 2024

file format

Portable Document Format

1 reference

DOI

https://api.crossref.org/works/10.1007/S00228-010-0883-5

http://link.springer.com/article/10.1007/s00228-010-0883-5/fulltext.html

29 July 2024

1 reference

https://api.crossref.org/works/10.1007/S00228-010-0883-5

http://link.springer.com/content/pdf/10.1007/s00228-010-0883-5

29 July 2024

1 reference

DOI

https://api.crossref.org/works/10.1007/S00228-010-0883-5

European Journal of Clinical Pharmacology

29 July 2024

published in

1 reference

26 November 2017

volume

67

1 reference

26 November 2017

issue

1

1 reference

26 November 2017

page(s)

47-54

1 reference

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00228-010-0883-5

Digoxin pharmacokinetics and MDR1 genetic polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-010-0883-5

Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genes.

21 January 2018

1 reference

12 December 2020

MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients

1 reference

12 December 2020

The genetic determinants of the CYP3A5 polymorphism

1 reference

12 December 2020

Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses

1 reference

12 December 2020

Donepezil use in Alzheimer disease

1 reference

12 December 2020

The CYP3A4*3 allele: is it really rare?

1 reference

12 December 2020

Determination of donepezil, an acetylcholinesterase inhibitor, in human plasma by high-performance liquid chromatography with ultraviolet absorbance detection

1 reference

12 December 2020

Phenotype-genotype variability in the human CYP3A locus as assessed by the probe drug quinine and analyses of variant CYP3A4 alleles

1 reference

12 December 2020

In vivo evaluation of P-glycoprotein modulation of 8 PET radioligands used clinically.

1 reference

12 December 2020

CYP3A5 genotype has significant effect on quinine 3-hydroxylation in Tanzanians, who have lower total CYP3A activity than a Swedish population

1 reference

12 December 2020

ABCB1 polymorphisms influence steady-state plasma levels of 9-hydroxyrisperidone and risperidone active moiety.

1 reference

12 December 2020

Genetic contribution to variable human CYP3A-mediated metabolism

1 reference

12 December 2020

Impact of the CYP2D6 polymorphism on steady-state plasma concentrations and clinical outcome of donepezil in Alzheimer's disease patients.

1 reference

12 December 2020

Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein.

1 reference

12 December 2020

Concurrent administration of donepezil HCl and ketoconazole: assessment of pharmacokinetic changes following single and multiple doses

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses

1 reference

12 December 2020

MDR1 genotype-related duodenal absorption rate of digoxin in healthy Japanese subjects

1 reference

12 December 2020

Significant genetic linkage of MDR1 polymorphisms at positions 3435 and 2677: functional relevance to pharmacokinetics of digoxin

1 reference

12 December 2020

Ile118Val genetic polymorphism of CYP3A4 and its effects on lipid-lowering efficacy of simvastatin in Chinese hyperlipidemic patients

1 reference

12 December 2020

Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects

1 reference

12 December 2020

Treatment of Alzheimer's disease: current status and new perspectives.

1 reference

12 December 2020

Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects

1 reference

12 December 2020

Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients

1 reference

12 December 2020

CYP3A5*3 and CYP3A4*1B Allele Distribution and Genotype Combinations: Differences Between Spaniards and Central Americans

1 reference

12 December 2020

1 reference

12 December 2020

CYP3A5 variant allele frequencies in Dutch Caucasians

1 reference

12 December 2020

Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects.

1 reference

12 December 2020

Irinotecan pathway genotype analysis to predict pharmacokinetics

1 reference

12 December 2020

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

1 reference

12 December 2020

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

1 reference

12 December 2020

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

1 reference

12 December 2020

CYP3A4-V polymorphism detection by PCR-restriction fragment length polymorphism analysis and its allelic frequency among 199 Dutch Caucasians

1 reference

12 December 2020

Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene

1 reference

12 December 2020

Identification of functionally variant MDR1 alleles among European Americans and African Americans

1 reference

12 December 2020

MDR1 genotype is associated with hepatic cytochrome P450 3A4 basal and induction phenotype.

1 reference

12 December 2020

Genotype relationships in the CYP3A locus in Caucasians

1 reference

12 December 2020

Ethnic differences in genetic polymorphisms of CYP2D6, CYP2C19, CYP3As and MDR1/ABCB1.

1 reference

12 December 2020

CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: evidence for an allelic variant with altered catalytic activity

1 reference

12 December 2020

Concurrent administration of donepezil HCl and cimetidine: assessment of pharmacokinetic changes following single and multiple doses

1 reference

12 December 2020

Concurrent administration of donepezil HCl and sertraline HCl in healthy volunteers: assessment of pharmacokinetic changes and safety following single and multiple oral doses

1 reference

12 December 2020

Identifiers

DOI

1 reference

26 November 2017

1 reference